Myriad Genetics (MYGN) Interest & Investment Income (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Interest & Investment Income of $700000.0 for Q1 2026, up 133.33% year-over-year from $300000.0 in Q1 2025, and down 12.5% quarter-over-quarter from $800000.0 in Q4 2025.
Myriad Genetics (MYGN) Interest & Investment Income (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Interest & Investment Income for 18 consecutive years, with $700000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 133.33% year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $2.2 million (up 57.14% YoY), while the FY2025 annual figure was $1.8 million, up 5.88% from the prior year.
- Interest & Investment Income retreated to $700000.0 in Q1 2026 per MYGN's latest filing, from $800000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.1 million in Q3 2022 and bottomed at $100000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $547058.8 across 5 years, with a median of $500000.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 900.0% — and 2024, when it tumbled 57.14%.
- Myriad Genetics' Interest & Investment Income stood at $1.0 million in 2022, then fell by 30.0% to $700000.0 in 2023, then sank by 57.14% to $300000.0 in 2024, then surged by 166.67% to $800000.0 in 2025, then retreated by 12.5% to $700000.0 in 2026.
- Business Quant data shows MYGN's Interest & Investment Income at $700000.0 in Q1 2026, $800000.0 in Q4 2025, and $500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 207.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 61.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 13.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 7.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 606,000.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 8.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 5.60 Mn |
| 10 | Myriad Genetics | 300.99 Mn | 185.79 Mn | 127.00 Mn | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 400,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 200,000.00 |